Enforcement Rules of the Communicable Disease Control Act Article 16

For the need of the control of communicable diseases, the central competent authority may entrust its subordinate Center for Disease Control to conduct the following matters:1. Matters concerning the management of infectious biological materials and bio safety of laboratories according to the regulations of Article 34 of the Act; 2. In accordance with the regulations of Paragraph 4, Article 39 of the Act, require medical institutions, physicians, or forensic medicine physicians to provide within a definite time, relevant information of patients of communicable diseases or cases showing adverse reaction due to potential hazards of immunization; 3. The collection of specimens for testing of communicable diseases in Subparagraph 1, Paragraph 1 of Article 46 of the Act, and the relevant inspection authority management provisions of Subparagraph 2, Paragraph 1 of Article 46 of the Act.4. Conduct matters related to the pathological autopsy examinations of remains died of communicable diseases or suspected communicable diseases or of suspected death due to hazards of immunization in accordance with regulations of Paragraph 2, Paragraph 3, Article 50 of the Act; 5. Conduct matters related to the quarantine of international and designated special ports in accordance with regulations of Article 58 through Article 60 of the Act.
中文原文 傳染病防治法施行細則第16條
中央主管機關為因應傳染病防治需要,得委任所屬疾病管制署辦理下列事項:
一、依本法第三十四條規定之感染性生物材料與實驗室生物安全管理事項。
二、依本法第三十九條第四項規定要求醫事機構、醫師或法醫師限期提供傳染病病人或疑似疫苗接種後產生不良反應個案之相關資料。
三、本法第四十六條第一項第一款傳染病檢體採檢及第二款檢驗機構管理之相關規定。
四、本法第五十條第二項、第三項規定之傳染病或疑似傳染病,或疑似預防接種致死屍體之病理解剖檢驗相關事項。
五、本法第五十八條至第六十條規定之國際及指定特殊港埠檢疫相關事項。

English translation for reference only; the Chinese text prevails. Not legal advice.